-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades Lipocine to Neutral

Benzinga·04/06/2026 12:06:41
Listen to the news
HC Wainwright & Co. analyst Yi Chen downgrades Lipocine (NASDAQ:LPCN) from Buy to Neutral.